These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17403969)

  • 1. A genetic etiology of pervasive developmental disorder guides treatment.
    Solomon M; Hessl D; Chiu S; Hagerman R; Hendren R
    Am J Psychiatry; 2007 Apr; 164(4):575-80. PubMed ID: 17403969
    [No Abstract]   [Full Text] [Related]  

  • 2. A family with fragile-X syndrome.
    Kerbeshian J; Burd L; Martsolf J
    J Nerv Ment Dis; 1984 Sep; 172(9):549-51. PubMed ID: 6590782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autism spectrum disorders - an overview of the current research status].
    Noterdaeme M
    Klin Padiatr; 2011 Mar; 223 Suppl 1():E1-15. PubMed ID: 21698558
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent NIMH clinical trials and implications for practice.
    Vitiello B
    J Am Acad Child Adolesc Psychiatry; 2008 Dec; 47(12):1369-74. PubMed ID: 19034188
    [No Abstract]   [Full Text] [Related]  

  • 5. What do we know about the serotonergic genetic heterogeneity in attention-deficit/hyperactivity and autistic disorders?
    Sinzig J; Lehmkuhl G
    Psychopathology; 2007; 40(5):329-37. PubMed ID: 17630501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autism, Asperger's and other oddities ... thoughts about treatment approaches.
    Kestenbaum CJ
    J Am Acad Psychoanal Dyn Psychiatry; 2008; 36(2):279-94. PubMed ID: 18593256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of challenging behavior, comorbid psychopathology, and Attention-Deficit/Hyperactivity Disorder in Fragile X Syndrome.
    Newman I; Leader G; Chen JL; Mannion A
    Res Dev Disabil; 2015 Mar; 38():7-17. PubMed ID: 25543996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The scope of occupational therapy services for individuals with autism spectrum disorders across the lifespan.
    Watling R; Tomchek S; LaVesser P;
    Am J Occup Ther; 2005; 59(6):680-3. PubMed ID: 16363193
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significant progress in the genetic origin of Martin-Bell syndrome including diagnostic consequences].
    Hebebrand J; Warnke A; Remschmidt H
    Z Kinder Jugendpsychiatr; 1992 Sep; 20(3):197-202. PubMed ID: 1414026
    [No Abstract]   [Full Text] [Related]  

  • 10. Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link?
    Lo-Castro A; Curatolo P
    Brain Dev; 2014 Mar; 36(3):185-93. PubMed ID: 23726375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autism: in search of susceptibility genes.
    Lamb JA; Parr JR; Bailey AJ; Monaco AP
    Neuromolecular Med; 2002; 2(1):11-28. PubMed ID: 12230302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of enuresis and its association with attention-deficit/hyperactivity disorder among U.S. children: results from a nationally representative study.
    Shreeram S; He JP; Kalaydjian A; Brothers S; Merikangas KR
    J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):35-41. PubMed ID: 19096296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autism and other developmental brain disorders.
    Nat Med; 2009 May; 15(5):464. PubMed ID: 19424182
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome.
    AlOlaby RR; Sweha SR; Silva M; Durbin-Johnson B; Yrigollen CM; Pretto D; Hagerman RJ; Tassone F
    Brain Dev; 2017 Jun; 39(6):483-492. PubMed ID: 28242040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should tactile sensation impairment be considered in pharmacotherapy of pervasive developmental disorders? A case report.
    Ghanizadeh A
    Neuro Endocrinol Lett; 2008 Dec; 29(6):877-8. PubMed ID: 19112394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental associations between traits of autism spectrum disorder and attention deficit hyperactivity disorder: a genetically informative, longitudinal twin study.
    Taylor MJ; Charman T; Robinson EB; Plomin R; Happé F; Asherson P; Ronald A
    Psychol Med; 2013 Aug; 43(8):1735-46. PubMed ID: 23158218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndrome.
    Frankenburg FR; Kando JC
    J Clin Psychopharmacol; 1994 Oct; 14(5):359-60. PubMed ID: 7806695
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral therapy, sertraline, or both in childhood anxiety.
    Birkett DP
    N Engl J Med; 2009 Jun; 360(23):2476; author reply 2477. PubMed ID: 19504765
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic counseling in autism and pervasive developmental disorders.
    Simonoff E
    J Autism Dev Disord; 1998 Oct; 28(5):447-56. PubMed ID: 9813780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.